Pharmaceutical manufacturing

In this Jan. 31, 2020, photo, Ann Lovell stands at the security checkpoint before her flight from Salt Lake City International Airport to San Diego. Lovell travels every few months to Tijuana, Mexico, to buy medication for rheumatoid arthritis — with tickets paid for by the state of Utah's public insurer. Lovell is one of about 10 state workers participating in a year-old program to lower prescription drug costs by having public employees buy their medication in Mexico at a steep discount compared to U.S. prices. (AP Photo/Rick Bowmer)
February 09, 2020 - 10:48 am
SALT LAKE CITY (AP) — Ann Lovell had never owned a passport before last year. Now, the 62-year-old teacher is a frequent flier, traveling every few months to Tijuana, Mexico, to buy medication for rheumatoid arthritis — with tickets paid for by the state of Utah’s public insurer. Lovell is one of...
Read More
French lab scientists in hazmat gear inserting liquid in test tube manipulate potentially infected patient samples at Pasteur Institute in Paris, Thursday, Feb. 6, 2020. Scientists at the Pasteur Institute developed and shared a quick test for the new virus that is spreading worldwide, and are using genetic information about the coronavirus to develop a potential vaccine and treatments. (AP Photo/Francois Mori)
February 06, 2020 - 8:41 pm
WASHINGTON (AP) — The flu-like virus that exploded from China has researchers worldwide once again scrambling to find a vaccine against a surprise health threat, with no guarantee one will arrive in time. Just days after Chinese scientists shared the genetic map of the culprit coronavirus,...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck is posting a 29% jump in fourth-quarter profit and it's spinning off its women's health division and other operations that churn out $6.5 billion in annual revenues. The drugmaker on Wednesday, Feb. 5, 2020 reported net income of $2.36 billion, up from $1.83 billion, a year earlier. (AP Photo/Seth Wenig, File)
February 05, 2020 - 7:43 am
Merck is posting a 29% jump in fourth-quarter profit and it's spinning off its women's health division and other operations that churn out $6.5 billion in annual revenues. The drugmaker on Wednesday reported net income of $2.36 billion, or 92 cents per share, up from $1.83 billion, or 69 cents per...
Read More
A worker wearing a protective suit stands in front of an electronic display board in the lobby of the Shanghai Stock Exchange building in Shanghai, Monday, Feb. 3, 2020. The Shanghai Composite index tumbled 8.7% Monday then rebounded slightly as Chinese regulators moved to stabilize markets reopening from a prolonged national holiday despite a rising death toll from a new virus that has spread to more than 20 countries. (AP Photo)
February 03, 2020 - 7:51 am
BANGKOK (AP) — China's main stock index tumbled nearly 8% Monday as the country's markets reopened and regulators sought to calm investors over the impact of a virus that has spread to more than 20 countries and killed more than 360 people. Other markets, including in Europe and Wall Street futures...
Read More
FILE - In this Nov. 23, 2015, file photo, the Pfizer logo is displayed at world headquarters in New York. Pfizer is reporting a $306 million loss for the fourth quarter after it shifted its consumer health business into a joint venture last year. It narrowly Wall Street expectations for net income when nonrecurring events are removed. The biggest US drugmaker on Tuesday, Jan. 28, 2020 reported a net loss of 6 cents per share. (AP Photo/Mark Lennihan, File)
January 28, 2020 - 4:31 pm
Pfizer's ongoing restructuring is significantly reducing revenue, resulting in a $337 million loss in its fourth quarter and a miss of Wall Street's profit expectations. The results and Pfizer's 2020 financial forecasts didn't please investors, who drove Pfizer shares down more than 4%, an...
Read More
FILE - In this Aug. 4, 2017, file photo, Martin Shkreli leaves federal court in New York while on trial for deceiving investors in a pair of failed hedge funds. On Monday, Jan. 27, 2020, New York state and federal authorities sued the imprisoned Shkreli, also known as "Pharma Bro," over business tactics that helped make him the bad-boy face of profiteering in pharmaceuticals, seeking to bar him from the industry for life. (AP Photo/Seth Wenig, File)
January 27, 2020 - 8:27 pm
NEW YORK (AP) — State and federal authorities sued imprisoned entrepreneur Martin Shkreli on Monday over tactics that shielded a profitable drug from competition after a price hike made the so-called “Pharma Bro” infamous. Shkreli was scorned as the bad-boy face of pharmaceuticals profiteering...
Read More
January 25, 2020 - 11:25 am
NEW YORK (AP) — Stocks around the world fell this week on worries that a new type of virus in China may ultimately hit profits for companies from Wuhan to Washington. The World Health Organization has held off on calling the outbreak a global health emergency but says it may become one. The virus...
Read More
President Donald Trump delivers the opening remarks at the World Economic Forum, Tuesday, Jan. 21, 2020, in Davos. (AP Photo/ Evan Vucci)
Associated Press
January 21, 2020 - 5:38 pm
DAVOS, Switzerland (AP) — President Donald Trump looked past the impeachment drama unfolding in Washington on Tuesday, turning his speech at an economic forum in the Swiss Alps into an unabashed sales pitch for the “blue-collar boom” in the U.S. economy that he says took place on his watch. Trump...
Read More
French President Emmanuel Macron delivers a speech as he visits a plant of British-Swedish pharmaceutical group Astrazeneca in Dunkirk, northern France, Monday, Jan. 20, 2020. French President Emmanuel Macron is hosting 180 international business leaders later today at the Palace of Versailles in a bid to promote France's economic attractiveness despite over six weeks of crippling strikes over his government's planned pension changes.(Denis Charlet/Pool Photo via AP)
January 20, 2020 - 10:00 am
PARIS (AP) — France's president is taking on the role of salesman in chief for his strike-battered country. Emmanuel Macron used the splendor of the Palace of Versailles to woo international business leaders on Monday, insisting that his reforms are attracting investors despite six weeks of...
Read More
FILE - In this July 23, 2019, file photo, Gov. Gavin Newsom talks to reporters at his Capitol office, in Sacramento, Calif. California could become the first state with its own prescription drug label. Newsom announced Thursday, Jan. 9, 2020, he wants California to contract with generic drug companies to make prescription medications on behalf of the state so it can sell them to the public. He said the goal is to lower prices by increasing competition in the generic market. State lawmakers must approve the plan before it can take effect. (AP Photo/Rich Pedroncelli, File)
January 09, 2020 - 8:39 pm
SACRAMENTO, Calif. (AP) — California could become the first state to make its own prescription drugs under a proposal announced Thursday by Gov. Gavin Newsom, who says it would “take the power out of the hands of greedy pharmaceutical companies." The Democratic governor wants the nation's most...
Read More

Pages